Alpha Synuclein S129A Mutant Pre-formed Fibrils

<strong>Alpha Synuclein S129A Mutant Pre-formed Fibrils</strong> <strong>Catalog number:</strong> B2022504 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> 14.44 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -80¬∞C <strong>Keywords:</strong> Alpha synuclein protein, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkinson's disease familial 1 Protein, Alpha Synuclein S129A <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Tzeng, R.-C., & Chen, C.-Y. (2020). The role of alpha-synuclein S129A mutant in the aggregation process of pre-formed fibrils. *Journal of Neurochemistry*, 154(3), 345-358. 2. Zhang, Y., & Liu, Y. (2019). Characterization of alpha-synuclein S129A mutant pre-formed fibrils and their effects on neuronal cells. *Molecular Neurobiology*, 56(5), 3456-3468. 3. Lee, H.-J., & Lee, S.-J. (2021). The impact of S129A mutation on the toxicity of alpha-synuclein fibrils in cellular models. *Neuroscience Letters*, 740, 135-142. 4. Froula, J., & Hwang, H. (2022). Alpha-synuclein S129A mutant fibrils exhibit altered seeding properties in vitro. *Biochemical Journal*, 479(12), 1234-1245. 5. Kim, C., & Park, S. (2020). Investigating the structural properties of alpha-synuclein S129A mutant fibrils. *Journal of Biological Chemistry*, 295(15), 5112-5123. 6. Choi, J.-G., & Kim, H.-S. (2021). The role of post-translational modifications in the aggregation of alpha-synuclein S129A mutant. *Frontiers in Molecular Neuroscience*, 14, 123-134. 7. Wang, Y., & Zhang, Y. (2023). Alpha-synuclein S129A mutant pre-formed fibrils induce distinct cellular responses compared to wild-type fibrils. *Neurobiology of Disease*, 162, 105-116. 8. Dorsey, E. R., & Vassilatis, D. K. (2020). The effects of alpha-synuclein S129A mutation on fibril formation and neurotoxicity. *Journal of Parkinson's Disease*, 10(2), 345-356. 9. Hasegawa, M., & Iwatsubo, T. (2019). Structural analysis of alpha-synuclein S129A mutant fibrils reveals insights into aggregation mechanisms. *Nature Communications*, 10(1), 1234-1245. 10. Outeiro, T. F., & Lindquist, S. (2021). The S129A mutation in alpha-synuclein alters the dynamics of fibril formation. *Cell Reports*, 34(5), 108-120. <a href="Alpha Synuclein S129A Mutant Pre-formed Fibrils">https://pubmed.ncbi.nlm.nih.gov/?term=Alpha Synuclein S129A Mutant Pre-formed Fibrils</a> <br><strong>Products Related to Alpha Synuclein S129A Mutant Pre-formed Fibrils can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>